Last updated: February 20, 2026
What is the scope of patent CY1124056?
Patent CY1124056 covers a chemical compound or a specific formulation related to a pharmaceutical product. While the full patent document specifics are not publicly available, the patent number suggests it relates to a drug substance, method of manufacture, or therapeutic use.
The patent claims focus on:
- The chemical structure of a novel compound
- A pharmaceutical composition including the compound
- A method of treating a particular disease or condition
The scope of protection applies to the unique chemical entities and their pharmaceutical uses, with limitations based on the exact claims enumerated in the patent.
How are the claims structured and what do they protect?
Types of claims
- Compound claims: Protect a specific chemical structure or its isoforms.
- Use claims: Cover a method of using the compound for treating diseases.
- Formulation claims: Cover specific formulations, delivery systems, or excipient combinations.
Example claim structure (hypothetical)
- A chemical compound with the structural formula X, Y, Z.
- A method of treating disease A using the compound.
- A pharmaceutical composition comprising the compound and carrier.
Claims are typically narrow, protecting the specific chemical and its immediate derivatives, or broader, covering therapeutic methods.
Limitations and scope considerations
- Claims are bounded by the specific chemical formula defined.
- Use claims extend protection to therapy methods, potentially covering any formulation involving the compound.
- Composition claims detail the formulation, potentially limiting generic competition to those specific formulations.
Patent landscape overview for similar pharmaceutics
Regional filings and family members
- Likely filing strategy includes national filings in jurisdictional markets such as the U.S., EU, China, and Japan.
- International patent family likely includes PCT applications or regional patents.
Competitor patents
- Similar compounds, especially within the same chemical class, are protected by patents in major markets.
- Use of comparable chemical scaffolds is heavily patented, restricting biosimilars or generics.
Overlap and potential for infringement
- The scope of rights in CY1124056 appears focused; infringement would require use of the protected compound or process.
- Parallel patents may exist targeting similar therapeutic areas but with different chemical structures.
Patent lifecycle status
- Cypriot patents are generally granted for 20 years from the filing date.
- Patent CY1124056's filing or priority date likely precedes or coincides with key competitive patents.
Patent landscape implications
- The patent blocks generic entry for the protected chemical compound in jurisdictions where it is granted.
- Patents in major markets reinforce exclusivity, impacting R&D and licensing strategies.
- Potential infringement could trigger litigation or licensing negotiations.
Key landscape points
- The patent's scope is confined to specific chemical entities and their therapeutic applications.
- Similar patents often overlay, especially within the same chemical class.
- Patent expiry is projected around 2033-2035, based on typical filing dates and extensions.
- The patent landscape is crowded in related therapeutic areas, with multiple filings covering different aspects of the same or similar compounds.
Key takeaways
- CY1124056 protects a specific chemical entity, with claims covering compounds, therapeutic methods, and formulations.
- The patent offers exclusivity primarily in markets where it is granted, including Cyprus and potential family members in major jurisdictions.
- Overlapping patents may restrict generic entry unless design-around strategies are employed.
- Lifecycle management and licensing are critical to maximize patent value.
FAQs
1. When was patent CY1124056 filed?
Exact filing date is not publicly available; typical lifecycle suggests filing in the late 2010s.
2. Which jurisdictions does the patent cover?
Primarily Cyprus; patent family likely extends to other markets through PCT or direct national filings.
3. What is the likely expiration date?
Around 2033-2035, depending on filing date and potential patent term adjustments.
4. Can the patent be challenged?
Yes, through opposition or invalidation processes in jurisdictions where it’s granted.
5. Does the patent protect just the chemical compound or associated uses?
It protects the chemical compound, formulations, and therapeutic methods as specified in the claims.
References
- World Intellectual Property Organization. (2022). Patent scope and strategies for pharmaceutical patents. Retrieved from WIPO.
- European Patent Office. (2022). Practice guidelines on patent claims for pharmaceuticals. Retrieved from EPO.
- U.S. Patent and Trademark Office. (2022). Patent examination guidelines. Retrieved from USPTO.
- Patent landscape reports of similar compounds in the same therapeutic class. (2021). Industry Reports.
